دورية أكاديمية
أعرض في EDS

Risk of inpatient epistaxis admission related to oral anticoagulation medication use

التفاصيل البيبلوغرافية
العنوان: Risk of inpatient epistaxis admission related to oral anticoagulation medication use
المؤلفون: Margaret B. Mitchell, Alan D. Workman, Richard Lu, Neil Bhattacharyya
المصدر: Laryngoscope Investigative Otolaryngology, Vol 8, Iss 4, Pp 824-826 (2023)
بيانات النشر: Wiley, 2023.
سنة النشر: 2023
المجموعة: LCC:Otorhinolaryngology
LCC:Surgery
مصطلحات موضوعية: admission, anticoagulation, aspirin, clopidogrel, DOAC, epistaxis, Otorhinolaryngology, RF1-547, Surgery, RD1-811
الوصف: Abstract We utilized a case control study to determine if novel oral anticoagulants were associated with a higher risk of inpatient epistaxis admission. Adult patients admitted with a principal diagnosis of epistaxis in 2019–2021 were identified as well as a control group of patients matched 1:1 for age, sex, race, and medical comorbidities. For both cohorts, the presence or absence of an oral anticoagulant, classified as vitamin K inhibitors, direct oral anticoagulants (DOAC) or platelet inhibitors, was identified. 158 adult unique inpatient admissions with a principal diagnosis of epistaxis were identified. Vitamin K inhibition was present in 5.7% of cases versus 0.6% of controls (p = 0.02; OR 9.48, range 1.19‐75.77), DOACs in 4.4% of cases versus 5.1% of controls (p = 1.0) and platelet inhibitors in 2.5% of cases versus 3.8% of controls (p = 0.75). We concluded vitamin K inhibitors, compared to DOACs and platelet inhibitors, may be associated with higher likelihood of epistaxis admission.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2378-8038
Relation: https://doaj.org/toc/2378-8038
DOI: 10.1002/lio2.1111
URL الوصول: https://doaj.org/article/fd8f6bb9561e4f7fb37dbd8585ac2cbf
رقم الأكسشن: edsdoj.fd8f6bb9561e4f7fb37dbd8585ac2cbf
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:23788038
DOI:10.1002/lio2.1111